Bioinvent Terminates Current BI-505 Phase II Study

9. Dezember 2016 INDIZES WEUR

BioInvent International AB (OMXS: BINV) is focused on developing a first-in-class and best-in-class pipeline of antibody …
(Orginal – Story lesen…)

Tags: atx cac ftse ibex omxs

You may also like...